Active, Not Recruiting
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
NCT03891953
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Novartis Investigative Site Dresden, Saxony, Germany